Mega Genomics

Mega Genomics PP&E per Employee

The PP&E per Employee of Mega Genomics (6667.HK) as of Nov 19, 2026 is 305,056.63 CNY. In the previous year, PP&E per Employee was 346,281.91 CNY — a change of -11.91% (lower).

PP&E per Employee

305,056.63CNY

YoY

-11.91%

Last updated:

PP&E per Employee of Mega Genomics is 2025 305,056.63 CNY. PP&E per Employee of Mega Genomics was 2024 346,281.91 CNY. It decreases by -11.91% lower compared to the previous year.

The Mega Genomics PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2019
282,812.73 CNY
Jan 1, 2020
234,505.62 CNY
Jan 1, 2021
231,575.47 CNY
Jan 1, 2022
217,520.61 CNY
Jan 1, 2023
352,243.45 CNY
Jan 1, 2024
346,281.91 CNY
Jan 1, 2025
305,056.63 CNY
The Mega Genomics PP&E per Employee history
YEARPP&E per EmployeeYoY
305,056.63CNY-11.91%
346,281.91CNY-1.69%
352,243.45CNY+61.94%
217,520.61CNY-6.07%
231,575.47CNY-1.25%
234,505.62CNY-17.08%
282,812.73CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mega Genomics Stock analysis

What does Mega Genomics do? Mega Genomics Ltd. generates revenue through three business segments. The Consumer Genetic Testing Services segment offers nutrition and metabolism testing, cancer risk assessment, chronic disease susceptibility analysis, pharmacogenetic testing, and infectious disease testing to individual consumers. The Cancer Screening Services segment provides specific tests including Septin9 for colorectal cancer, Syndecan-2 (SDC2) for colorectal cancer, and ring finger protein 180 (RNF180)/Septin9 for gastric cancer screening. The Other Services segment delivers genetic research and analysis services to third-party research institutions, creating additional revenue streams from institutional partnerships. The primary buyers for Consumer Genetic Testing Services are individual consumers seeking personalized health insights. Cancer Screening Services are utilized by healthcare providers and patients for early detection of colorectal and gastric cancers. Third-party research institutions purchase genetic research and analysis services from the Other Services segment to support their scientific studies and development projects. Mega Genomics Ltd. serves distinct market segments: individual consumers for genetic testing, healthcare providers for cancer screening, and research institutions for specialized genetic analysis. The company's revenue model relies on direct consumer sales, healthcare provider contracts, and institutional research partnerships to sustain its operations and growth. Mega Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mega Genomics stock

PP&E per Employee of Mega Genomics is 305,056.63 CNY in 2025.

PP&E per Employee of Mega Genomics changed from 346,281.91 CNY to 305,056.63 CNY, representing a -11.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee Mega Genomics since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Mega Genomics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Mega Genomics

All Key Metrics — Mega Genomics